BIRC3 and hepatocellular carcinoma: CIAP2 has become an exciting research topic because of its exceedingly elevated expression in a wide range of cancers, including gallbladder cancer [27], gastric cancer [56], renal cell carcinomas [57], and, unsurprisingly, HCC [28].